Consultation – The Future Strategy for Batch Testing of Medicinal Products in Great Britain Consultation – The Future Strategy for Batch Testing of Medicinal Products in Great Britain The Department of Health and Social... Consultation – The Future Strategy for Batch Testing of Medicinal Products in Great Britain
CMDh May 2022 Meeting – Report CMDh May 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh May 2022 Meeting – Report
Global Self Care Federation Launches Key Highlights on Socio-Economic Value of Self-Care Global Self Care Federation Launches Key Highlights on Socio-Economic Value of Self-Care On 26 May 2022, the Global Self Care... Global Self Care Federation Launches Key Highlights on Socio-Economic Value of Self-Care
EMA Webinar Summary – Digital Application Dataset Integration Human Medicinal Products and Product Management Service EMA Webinar Summary – Digital Application Dataset Integration Human Medicinal Products and Product Management Service The European Medicines Agency (EMA)... EMA Webinar Summary – Digital Application Dataset Integration Human Medicinal Products and Product Management Service
EMA Clinical Trials Information System Bitesize Talks 2022 EMA Clinical Trials Information System Bitesize Talks 2022 The Clinical Trials Information System (CTIS) went live on 31 January 2022... EMA Clinical Trials Information System Bitesize Talks 2022
One Substance One Assessment – Public Information Session One Substance One Assessment – Public Information Session The Chemicals Strategy for Sustainability sets the objective to move towards ‘one... One Substance One Assessment – Public Information Session
MHRA Publishes Medicines Shortages Guidance MHRA Publishes Medicines Shortages Guidance MHRA has published the guidance ‘Medicines shortages: regulatory processes to manage supply... MHRA Publishes Medicines Shortages Guidance
PAGB Response to MHRA Public Consultation on Reclassification of Aquiette 2.5 mg Tablets to a Pharmacy Medicine PAGB Response to MHRA Public Consultation on Reclassification of Aquiette 2.5 mg Tablets to a Pharmacy Medicine Following the launch... PAGB Response to MHRA Public Consultation on Reclassification of Aquiette 2.5 mg Tablets to a Pharmacy Medicine
MHRA February Board Meeting Documents MHRA February Board Meeting Documents The agenda and board papers from the MHRA board meeting on 15... MHRA February Board Meeting Documents
EMA HMPC – Guideline on Quality of Herbal Medicinal Products / Traditional Herbal Medicinal Products Published EMA HMPC – Guideline on Quality of Herbal Medicinal Products / Traditional Herbal Medicinal Products Published The European Medicines Agency’s... EMA HMPC – Guideline on Quality of Herbal Medicinal Products / Traditional Herbal Medicinal Products Published
MHRA – March and April 2022 Licensing Time-based Performance Measures Published MHRA – March and April 2022 Licensing Time-based Performance Measures Published MHRA publish data on the expected time taken to... MHRA – March and April 2022 Licensing Time-based Performance Measures Published
MHRA Publishes Compliance Monitor Overview and Application Process MHRA Publishes Compliance Monitor Overview and Application Process From April 2022, MHRA will run a pilot scheme monitoring companies failing... MHRA Publishes Compliance Monitor Overview and Application Process
